ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Astellas Pharma US 

1 Astellas Way

Northbrook  Illinois  60062  U.S.A.
Phone: 800-695-4321 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals

Collaborations

Gilead 

Gilead (Seattle, WA) 





 Company News
Astellas Pharma US And BlackDoctor.org (BDO) Team Up To Offer Health Education At The 2015 CIAA Tournament Fan Fest 2/20/2015 1:37:13 PM
Astellas Pharma US Release: XTANDI™ (Enzalutamide) Now Approved In Europe For The Treatment Of Men With Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve 12/2/2014 9:16:16 AM
Medivation, Inc. (MDVN) And Astellas Pharma US Announce Phase 3 Study Of Enzalutamide in Men With High-Risk, Hormone-Sensitive, Non-Metastatic Prostate Cancer That Has Recurred Following Definitive Local Therapy 10/31/2014 12:45:31 PM
Astellas Pharma US Teams Up With USA Rugby And Men's Health Network To Encourage Chicagoans To Answer The Challenge For Better Health 10/15/2014 8:13:43 AM
Brian McLellan Promoted To President Of Astellas Pharma US 10/2/2014 8:46:16 AM
Astellas Pharma US Appoints Karl Uhlendorf As Communications And Advocacy Director 6/24/2014 8:21:23 AM
Astellas Pharma US Release: Enzalutamide Data, Including Additional Results From The PREVAIL Trial, To Be Presented At Upcoming American Society of Clinical Oncology Annual Meeting 5/15/2014 7:04:42 AM
Astellas Pharma US Promotes Jeffrey Bloss To SVP Of Medical Affairs For The Americas 4/16/2014 6:35:08 AM
Astellas Pharma US Announces European Regulatory Submission For XTANDI® (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer 4/3/2014 9:23:22 AM
Astellas Pharma US Secures Exclusive Rights To Commercialize Isavuconazole In The U.S. And Canada 2/28/2014 10:58:47 AM
12345678